Company Overview
- Headquarters
- 21540 30th Dr SE Suite 260, Bothell WA
- Website
- curevovaccine.com
- Phone
- (206) 492-5722
- Employees
- 46
- Founded in
- 2017
- Industry
- BioTech/Drugs
- NAICS Code
-
NAICS Code 325414 CompaniesNAICS Code 3254 CompaniesNAICS Code 32 CompaniesNAICS Code 32541 CompaniesNAICS Code 325 Companies
- SIC Code
-
SIC Code 28 CompaniesSIC Code 283 Companies
Financials & Stats
Revenue
$10B
Who is Curevo Inc
Curevo Inc. is a biotechnology company based in Bothell, Washington. The company employs 46 people and generates over $10,000 in annual revenue. Curevo focuses on the development of safe and effective vaccines for prevalent illnesses in both the Asian and United States markets. Curevo specializes in combining advanced protein science and adjuvant technology to accelerate the development of new vaccine candidates. Their target diseases are those lacking effective current vaccine solutions. To achieve its goals, Curevo collaborates with key research institutions including the South Korean Mogam Institute for Biomedical Research, GC Pharma, and the Infectious Disease Research Institute in Seattle, Washington. For more information, visit curevovaccine.com.
Company Leadership
Companies Similar to Curevo Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Curevo Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 10M | 18 | Arizona City, AZ | 1998 | |
| 10M | 9 | San Diego, CA | ||
| 10M | 6 | Campbell, CA | 2011 | |
| 10M | 2 | Torrington, WY | ||
| 10M | 1 | San Diego, CA | 2016 |